These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11040330)

  • 21. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
    Wang S; Liao Z; Wei X; Liu HH; Tucker SL; Hu CS; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1399-407. PubMed ID: 16997503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy.
    Jin H; Tucker SL; Liu HH; Wei X; Yom SS; Wang S; Komaki R; Chen Y; Martel MK; Mohan R; Cox JD; Liao Z
    Radiother Oncol; 2009 Jun; 91(3):427-32. PubMed ID: 18937989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy.
    Tsougos I; Nilsson P; Theodorou K; Kjellén E; Ewers SB; Jarlman O; Lind BK; Kappas C; Mavroidis P
    Phys Med Biol; 2007 Feb; 52(4):1055-73. PubMed ID: 17264370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy.
    Yorke ED; Jackson A; Rosenzweig KE; Merrick SA; Gabrys D; Venkatraman ES; Burman CM; Leibel SA; Ling CC
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):329-39. PubMed ID: 12243805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosimetric definitions of total lung volumes in calculating parameters predictive for radiation-induced pneumonitis.
    Kabolizadeh P; Kalash R; Huq MS; Greenberger JS; Heron DE; Beriwal S
    Am J Clin Oncol; 2015 Aug; 38(4):401-4. PubMed ID: 24064747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer.
    Tucker SL; Jin H; Wei X; Wang S; Martel MK; Komaki R; Liu HH; Mohan R; Chen Y; Cox JD; Liao Z
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):691-8. PubMed ID: 19836159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer.
    Yang J; Xu T; Gomez DR; Yuan X; Nguyen QN; Jeter M; Song Y; Hahn S; Liao Z
    Oncotarget; 2017 Jun; 8(26):43080-43090. PubMed ID: 28574846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An improved model for predicting radiation pneumonitis incorporating clinical and dosimetric variables.
    Jenkins P; Watts J
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1023-9. PubMed ID: 21543165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of radiation pneumopathy and generalised radiological changes after radiotherapy are independent negative prognostic factors for survival in non-small cell lung cancer patients.
    Farr KP; Khalil AA; Knap MM; Møller DS; Grau C
    Radiother Oncol; 2013 Jun; 107(3):382-8. PubMed ID: 23726117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
    Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
    Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
    Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
    Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In regard to De Jaeger et al.: significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer (INT J RADIAT ONCOL BIOL PHYS 2004;58:1378-1387).
    Anscher MS; Kong FM
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1276-7. PubMed ID: 15752910
    [No Abstract]   [Full Text] [Related]  

  • 33. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer.
    Robnett TJ; Machtay M; Vines EF; McKenna MG; Algazy KM; McKenna WG
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):89-94. PubMed ID: 10924976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung Size and the Risk of Radiation Pneumonitis.
    Briere TM; Krafft S; Liao Z; Martel MK
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):377-84. PubMed ID: 26675062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Application of standardized uptake value for FDG PET-CT in predicting radiation pneumonitis].
    Zhang Y; Yu YH; Yu JM; He W; Fu Z; Guo SF; Liu XJ; Cong CS
    Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):622-5. PubMed ID: 20021952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation.
    Rube CE; Uthe D; Schmid KW; Richter KD; Wessel J; Schuck A; Willich N; Rube C
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1033-42. PubMed ID: 10863076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel method to incorporate the spatial location of the lung dose distribution into predictive radiation pneumonitis modeling.
    Vinogradskiy Y; Tucker SL; Liao Z; Martel MK
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1549-55. PubMed ID: 21741183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma Levels of IL-8 and TGF-β1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation Study.
    Wang S; Campbell J; Stenmark MH; Zhao J; Stanton P; Matuszak MM; Ten Haken RK; Kong FS
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):615-621. PubMed ID: 28581403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour response and radiation-induced lung injury in patients with recurrent small cell lung cancer treated with radiotherapy and concomitant interferon-alpha.
    Halme M; Hallman M; Ruotsalainen T; Piilonen A; Taskinen E; Pekonen M; Maasilta P; Mattson K
    Lung Cancer; 1999 Jan; 23(1):39-52. PubMed ID: 10100145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In response to Drs. Anscher and Kong.
    De Jaeger K; Seppenwoolde Y; Lebesque JV; Kampinga HH
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):308. PubMed ID: 16111602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.